Bioequivalence and Bioavailability Forum

PK model parameters IR vs MR mittyri 2019-09-02 22:15
- PK model parameters IR vs MR jag009 2019-09-03 16:07
  - PK model parameters IR vs MR mittyri 2019-09-03 16:54
- PK model parameters IR vs MR ElMaestro 2019-09-03 17:43
  - PK model parameters IR vs MR mittyri 2019-09-03 18:05
- Parameter-identifiability? Helmut 2019-09-07 13:03
  - transit compartments... mittyri 2019-09-07 22:25
    - No organs in (Pop)PK Helmut 2019-09-08 10:56

Intrasubject CV for fed studies jag009 2019-08-22 14:53
- Intrasubject CV for fed studies ElMaestro 2019-08-22 21:56
- Intrasubject CV for fed studies zaibo liu 2019-08-23 02:54
  - Intrasubject CV for fed studies jag009 2019-09-04 06:32

Intrasubject CV for ibuprofen jag009 2019-09-03 16:09

Dose curve Sundar.M 2019-02-15 13:37

Concentration-time graphs and higher last sampling time point Smitha 2018-11-29 11:22
- Concentration-time graphs and higher last sampling time point ElMaestro 2018-11-29 12:15
  - Concentration-time graphs and higher last sampling time point Smitha 2018-11-30 06:43
  - Concentration-time graphs and NCA Helmut 2019-02-02 17:30

PK/PD Index PKBR 2019-01-30 14:38
- fAUC0-24 / MIC index mittyri 2019-01-31 23:12

Simulation plasma and tissue profile PKBR 2019-01-30 01:58
- Try to find suitable PK model mittyri 2019-01-31 23:01

Dose-proportionality versus dose-linearity martin 2018-08-03 10:25
- Dose-proportionality versus dose-linearity ElMaestro 2018-08-03 11:21
  - Dose-proportionality versus dose-linearity Ben 2018-08-06 19:39
    - Dose-proportionality versus dose-linearity martin 2018-08-07 13:04

Single PK parameters from multiple PK parameters asjrm 2017-11-19 00:44
- Single PK parameters from multiple PK parameters jag009 2017-11-19 06:32
- PK parameters from multiple doses Helmut 2017-11-19 10:24
  - PK parameters from multiple doses Yura 2017-11-21 11:48
  - PK parameters from multiple doses SDavis 2017-11-24 10:59
    - PK parameters from multiple doses nobody 2017-11-24 16:07
      - PK parameters from multiple doses SDavis 2017-11-24 22:09
        
        PK parameters from multiple doses nobody 2017-11-27 14:13
        
        PK parameters from multiple doses SDavis 2017-11-28 11:34
        
        PK parameters from multiple doses nobody 2017-11-28 11:51
        
        PK parameters from multiple doses SDavis 2017-11-28 11:54
- Single PK parameters from multiple PK parameters nobody 2017-11-21 14:54

Predict Bioavailability from Cmax and Half life ViPraj 2017-07-20 07:45
- Predict Bioavailability from Cmax and Half life Ohlbe 2017-07-20 09:59
  - Predict Bioavailability from Cmax and Half life ViPraj 2017-07-20 13:00

Multiple concentrations near LLOQ krishpk 2017-06-07 12:13

Handling samples with unknown sample collection time lechia 2017-05-18 23:47
- Handling samples with unknown sample collection time ElMaestro 2017-05-19 00:32
  - Handling samples with unknown sample collection time lechia 2017-05-19 22:01

Inclusion of 3 consecutive non-zero conc data with Cmax as a last Con in PK VSP 2017-05-07 21:53

absorption phase and elimination phase VSP 2017-04-25 18:28
- absorption / elimination Helmut 2017-04-26 13:26

dose linearity Clavulanic acid pguelen 2017-04-19 21:16
- dose linearity Clavulanic acid Helmut 2017-04-20 17:14

Admin contact
20,255 posts in 4,263 threads, 1,398 registered users;
online 10 (0 registered, 10 guests [including 8 identified bots]).
Forum time (Europe/Vienna): 12:10 CET

You should treat as many patients as possible with the new drugs
while they still have the power to heal. Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz